Lakefront Biotherapeutics (LKFT) Return on Capital Employed (QoQ) (2017 - 2026)

Lakefront Biotherapeutics (LKFT) Return on Capital Employed (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Lakefront Biotherapeutics 1.85 Bn -1.64 Bn 1.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 294.00
Dec 31, 2025 2,077.00
Sep 30, 2025 -832.00
Jun 30, 2025 141.00
Mar 31, 2025 -352.00
Mar 31, 2024 -48.00
Jun 30, 2020 -72.00
Mar 31, 2020 11.00
Dec 31, 2019 -512.00
Sep 30, 2019 1,650.00
Jun 30, 2019 -28.00
Mar 31, 2019 -181.00
Dec 31, 2018 325.00
Sep 30, 2018 -756.00
Jun 30, 2018 1,074.00
Jun 30, 2017 -74.00
Mar 31, 2017 811.00